A Prospective Randomized, Double-Blind, Multi-Center, Phase III Clinical Trial Evaluating the Efficacy and Safety of Olmesartan/Amlodipine plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia: A LEISURE Study.

Sang-Ho JoSeok Min KangByung-Su YooYoung Soo LeeHo Joong YounKyungwan MinJae Myung YuHyun Ju YoonWoo Shik KimGee Hee KimJae Hyoung ParkSeok Yeon KimCheol Ho Kim

Published in: Journal of clinical medicine (2022)

Olmesartan/amlodipine single pill plus rosuvastatin combination treatment for patients with both hypertension and dyslipidemia is effective and safe as compared to either olmesartan plus rosuvastatin or olmesartan plus amlodipine treatment.

Keyphrases

clinical trial
phase iii
double blind
blood pressure
open label
randomized controlled trial
hypertensive patients
phase ii
replacement therapy